Scientists Finally See How Ketamine Rewires the Depressed Brain
For the first time, researchers have captured direct brain images showing exactly how ketamine provides relief for depressed patients.
Read More
This Is Why You Don’t Go to Reddit for Ketamine Advice
A researcher recently spent six months combing through Reddit posts from patients using at home ketamine. What he found should alarm everyone.
Read More
FDA Grants Breakthrough Therapy Status to Psychedelic Inspired Postpartum Depression Drug
Reunion Neuroscience announced that its drug luvesilocin received Breakthrough Therapy Designation for the treatment of postpartum depression.
Read More
Compass Pathways Delivers Two Positive Phase 3 Results for Psilocybin in Depression
Compass Pathways just gave the psychedelic medicine field its biggest day in years.
Read More
New Grants Are Pushing Psychedelic Therapy Into End of Life Care
Seven organizations across the country received a combined $566,260 to advance research and training in this emerging field.
Read More
A Psychedelic That Mimics Meditation? New Research Says Yes
A powerful psychedelic may produce the same brain state as decades of meditation practice.
Read More
Washington State Senators Advance Bill to Legalize Psilocybin Therapy
Washington State took a significant step toward creating a regulated framework for therapeutic psilocybin use this week.
Read More
Colorado Poised to Become First State to Offer Regulated Ibogaine Therapy
Colorado regulators are reviewing rules that could add ibogaine to the state's Natural Medicine program -- making it the first to do so.
Read More
Psilocybin Shows Promise for Long COVID Symptoms in New Study
Millions of people continue to struggle with long COVID. Now, new research suggests psilocybin mushrooms may offer relief.
Read More
FDA Says Psychedelic Drug Applications Now “Fully a Third” of Workload
Federal officials are signaling growing momentum behind psychedelic drug development. The flood of applications reflects broad enthusiasm.
Read More